CPT vs drug reimbursement pathways. Cancer DTx enforcement discretion.

Issue 013.

Get E&O weekly. | Subscribe | Digital health research from Brian Dolan.

Welcome to E&O.

Last week's newsletter had a shouldn't-you-be-on-vacation? 82 percent open rate. Here's what's happening this week:

Your editor is feeling thirsty as the summer draws to a close. In a couple of weeks (Tuesday, August 13th) I'll be joining up with a few other Boston-area digital health groups to host a networking event in the city: The Summer of '19 Liquidity Event. It's organized by HealthTech Build, a local non-profit association where I'm a board member. If you want to grab a drink that night register here (https://www.eventbrite.com/e/summer-of-19-healthtech-liquidity-event-tickets-65739439433) and be sure to let me know, too.
Worried about digital health funding drying up? Two relevant data points for you that dropped this week:
> Boston-based, health technology-focused venture fund

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

CPT vs drug reimbursement pathways. Cancer DTx enforcement discretion.

Welcome to E&O.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.